1. Home
  2. BEEM vs GBIO Comparison

BEEM vs GBIO Comparison

Compare BEEM & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.72

Market Cap

34.8M

Sector

Technology

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.30

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
GBIO
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.8M
35.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BEEM
GBIO
Price
$1.72
$5.30
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$4.00
$10.67
AVG Volume (30 Days)
234.3K
40.1K
Earning Date
11-14-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,668,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$45.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$3.00
52 Week High
$4.04
$13.00

Technical Indicators

Market Signals
Indicator
BEEM
GBIO
Relative Strength Index (RSI) 37.50 50.63
Support Level $1.81 $5.22
Resistance Level $2.00 $5.64
Average True Range (ATR) 0.12 0.24
MACD 0.03 0.05
Stochastic Oscillator 19.44 59.32

Price Performance

Historical Comparison
BEEM
GBIO

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: